Commentary: Lack of topical cannabinoid research warrants caution
Shawn Kwatra, MD, with John Jesitus The dearth of data regarding topical cannabinoids in dermatology leads to a lack of confidence for prescribers. In this climate, experts recommend using FDA-approved treatments when possible, and, when needed, sticking to cannabinoids that have the most data behind them. “Topical cannabinoids are an exciting new potential therapeutic option […]